Efficacy and Safety of TAK-875 in Combination With Sitagliptin in Participants With Type 2 Diabetes Mellitus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01414920
Recruitment Status : Completed
First Posted : August 11, 2011
Last Update Posted : April 4, 2016
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : August 2012
  Study Completion Date : August 2012
  Certification/Extension First Submitted : March 4, 2016